Nissim Mashiach serves as Executive at Omrix Biopharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Nissim Mashiach has executed 8 insider transactions totaling $1.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on Oct 10, 2008 involved receiving (via award) 20,000 shares valued at $0.
Nissim Mashiach currently holds 27,000 shares of Omrix Biopharmaceuticals, Inc. (OMRI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Nissim Mashiach has been a net seller of OMRI stock. They have purchased $29.0K and sold $1.3M worth of shares.
Nissim Mashiach's most recent insider trade was on Oct 10, 2008, when they sold 20,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $14.50 |
| Discretionary |
| Dec 11, 2007 | OMRI | $194.0K | Option Exercise | 9,091 | $21.34 | Discretionary |
| Dec 11, 2007 | OMRI | $345.5K | Sale | 9,091 | $38.00 | Discretionary |
| Jan 16, 2007 | OMRI | $0 | Award | 5,000 | $N/A | Discretionary |
| Nov 9, 2006 | OMRI | $82.5K | Option Exercise | 30,000 | $2.75 | Discretionary |
| Nov 9, 2006 | OMRI | $976.3K | Sale | 42,728 | $22.85 | Discretionary |
| Nov 9, 2006 | OMRI | $216.0K | Option Exercise | 12,728 | $16.97 | Discretionary |